Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Japan has canceled an order for more than 140 million doses of Novavax’s Covid-19 vaccine, Takeda revealed in an SEC filing.
The country initially agreed in 2021 to purchase 150 million doses of the vaccine from Takeda, which has been producing Novavax’s vaccine at its Hikari-based facility. But after only purchasing 8.24 million doses, the Ministry of Health, Labour and Welfare has canceled the remaining 141.76 million doses.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.